Introduction {#s1}
============

During the development of complex multicellular organisms, changes in epithelial cell morphology are essential for the tissue-specific cell differentiation patterning that leads to the subsequent formation of functional organs ([@bib64]). This is particularly clear when considering the formation of the ocular lens, which has served as a model system to delineate many developmental pathways ([@bib15]; [@bib22]). The development of the mouse lens begins at embryonic day 9.5 when the optic vesicle extends toward the presumptive lens ectoderm, inducing the latter to thicken into a cuboidal layer of epithelial cells commonly referred to as the lens placode. At E10.5, the cells making up the lens placode undergo apical constriction to form the lens pit, which eventually closes at its anterior surface to form the lens vesicle ([@bib14]). After the newly differentiated primary fiber cells extend anteriorly from the posterior region of the lens vesicle, the anterior epithelial cells begin to migrate posteriorly towards the equatorial region of the lens, at which point they begin to differentiate into secondary fiber cells that continue to occupy the space within the lens interior. This process is accompanied by up to a 1000-fold increase in the length of the newly formed secondary fiber cells, which coordinate with the primary fiber cells to organize an elegant concave pattern that maintains the structural integrity and transparency of the mature lens ([@bib6]; [@bib41]; [@bib67]).

Previously proposed models that have been considered for the mechanism by which lens fiber cells elongate consist of microtubule reorganization, increased cell volume and actin dynamics ([@bib5]). Microtubules are prominent components of the cytoskeleton lining the plasma membrane of lens fiber cells. They are oriented longitudinally along the lens with their minus end towards the anterior pole and their plus ends facing the posterior ([@bib10]). which is consistent with the presence of microtubule organizing centers at the apical ends of lens fiber cells ([@bib35]). However, Beebe et al reported that Nocodazole inhibition of microtubule polymerization failed to disrupt fiber cell elongation in chick lens explants ([@bib7]). Instead, they proposed that the expansion of cell volume was the key mechanism by which fiber cells elongated to form the functional mature lens. However, utilizing precise measurement techniques, it was later found that there was no apparent increase in lens volume in vivo at the onset of fiber cell elongation ([@bib6]). The differentiation of lens epithelial cells into lens fiber cells is also associated with the assembly of actin filaments beneath the cortical membrane ([@bib73]). When this cortical actin structure was inhibited by cytochalasin D in lens explants, both the differentiation and elongation of lens cells were blocked. Nevertheless, neither the disruption of the cell adhesion molecules N-cadherin or β1-integrin nor the ablation of the actin regulators Rac1 and Rho completely prevented the lengthening of lens fiber cells ([@bib36]; [@bib39], [@bib40]; [@bib51]; [@bib53]). Consequently, how the actin cytoskeleton is controlled during fiber cell elongation has remained an open question.

Fibroblast Growth Factor (FGF) signaling is known to play an important role in lens cell differentiation and elongation. Transgenic expression of human FGF-1 using an αA-crystallin promoter was found to induce lens epithelial cells to acquire elongated shapes and fiber cell characteristics ([@bib60]). In explant cultures, FGF was also found to promote lens fiber cell differentiation and elongation in a dose dependent manner ([@bib37]; [@bib42]). Conversely, genetic ablation of FGF receptors leads to a complete loss of lens cell differentiation and elongation ([@bib78]). Several proteins have been implicated in the direct engagement with these active FGF receptors, including Frs2/3, Grb14, Shb, PLCγ and Crk ([@bib9]; [@bib29]). Of particular interests are Crk and the related protein Crkl, which are mammalian homologs of the viral *Crk* oncogene that prossess the ability to promote the tyrosine phosphorylation of cellular proteins ([@bib17]). Lacking intrinsic tyrosine kinase activity, the Crk family of proteins act as adaptors that transduce signals from upstream phosphotyrosine-containing proteins to downstream SH3-interacting partners ([@bib8]). Biochemical studies have shown that FGF2-stimulated endothelial cell proliferation is dependent on the binding of Crk to the phosphorylated tyrosine residue 463 in FGFR1 ([@bib32]). In line with this finding, *Crk* null mice display some of the cardiovascular and cranial features of Noonan syndrome, which is caused by aberrant Ras-MAPK signaling ([@bib49]; [@bib57]; [@bib61]; [@bib69]; [@bib70]). Crkl was also identified as a component of an FGF8-induced feed forward loop, resulting in anchorage-independent cell growth ([@bib63]). Consistent with this, the human *CRKL* gene lies within the chromosome 22q11 deletion region that causes DiGeorge syndrome, which shares the pharyngeal and cardiac defects seen in *Fgf8*-deficient mice ([@bib43]). Despite these findings implicating Crk and Crkl in FGF signaling, a recent study has shown that mutating their putative Y463 binding site in Fgfr1 did not produce any observable phenotype in transgenic mice ([@bib9]). Therefore, the potential role and mechanism of Crk proteins in FGF signaling remain uncertain.

In this study, we showed that the lens specific knockout of *Crk* and *Crkl* disrupted lens fiber cell elongation without affecting differentiation, suggesting that lens cell morphogenesis can be uncoupled from differentiation during development. FGF loss- and gain-of-function experiments demonstrated that Crk proteins act downstream of FGF signaling to enhance ERK phosphorylation. Contrary to the previous belief that Crk proteins directly bind to the Fgfr, we found that mutating the purported Crk docking site on Fgfr1 failed to perturb lens development or Crk phosphorylation. Instead, our data showed that Crkl was recruited to the Frs2/Shp2/Grb2 complex after FGF stimulation. Crk/Crkl deficient animals phenocopied Rac1 but not Rap1 mutants, and activation of Rac1 and Ras signaling partially reversed the observed lens elongation defects caused by the deletion of Crk and Crkl. These results show that the Crk family of adaptor proteins are essential partners of the Frs2/Shp2/Grb2 complex that forms during FGF signaling, and are specifically required for stimulating the actin reorganization that is necessary for the morphological shaping of lens cells.

Results {#s2}
=======

Ablation of Crk and Crkl caused lens defects {#s2-1}
--------------------------------------------

We observed that Crk and Crkl proteins displayed a restricted localization pattern in the lens. At E10.5, Crk and Crkl were predominantly confined to the apical side of the lens vesicle ([Figure 1A](#fig1){ref-type="fig"}, arrows), away from the basal side where integrins interact with the basement membrane ([Figure 1A](#fig1){ref-type="fig"}, dotted lines). By contrast, Crk and Crkl exhibited a more diffuse pattern at E12.5 when the posterior lens vesicle cells gave rise to the primary lens fibers ([Figure 1A](#fig1){ref-type="fig"}). However, by E14.5, Crk and Crkl were specifically enriched in the transitional zone where the lens epithelial cells begin to differentiate and elongate into the secondary lens fiber cells ([Figure 1A](#fig1){ref-type="fig"}, arrowheads). Using an antibody that recognizes the phosphorylated forms of both of these proteins, we were able to observe that the phosphorylation of Crk and Crkl also mainly occurs in the transition zone of the lens at this stage of development ([Figure 1B](#fig1){ref-type="fig"}, arrowheads). These results suggest that Crk activity is under dynamic regulation as the lens cells undergo successive morphological changes during development.

![Crk and Crkl are essential for lens development.\
(**A**) Crk and Crkl immunostaining were localized to the invaginating lens vesicle at E10.5 (arrows) and to the elongating lens fiber cells near the transitional zone of the lens at E14.5 (arrowheads). These staining patterns were specifically lost in the CrkCKO lens. The dotted lines enclose the region of the lens and the disorganization of the retina was marked with asterisks (**B**) The phosphorylation of both Crk and Crkl was noticeably absent in the CrkCKO lens (arrowheads). (**C**) The CrkCKO lens size was significantly reduced with the anterior lens epithelium rotated sideways (arrows) and the disorganized lens fiber cells markedly shortened (double headed arrows).](elife-32586-fig1){#fig1}

We next ablated *Crk* genes using *Pax6^Le^-Cre*, also known as *Le-Cre,* which is initially active in the lens placode and later in the lens epithelium ([@bib3]). As expected, this resulted in the loss of both Crk/Crkl and pCrk/pCrkl in the *Pax6^Le^-Cre;Crk^flox/flox^;Crkl^flox/flox^* (CrkCKO) lens after E10.5 ([Figure 1A and B](#fig1){ref-type="fig"}, dotted line). Although deletion of either *Crk* or *Crkl* alone did not perturb lens development ([Figure 1---figure supplement 1A--C](#fig1s1){ref-type="fig"}), the CrkCKO lens displayed a reduction in lens size, rotation of the lens epithelial layer, and disorganization of the lens fiber cells at E14.5 ([Figure 1C](#fig1){ref-type="fig"}, arrow). Using F-actin staining to better delineate individual cell shapes, we observed a significant reduction in the length of the lens fiber cells ([Figure 1C](#fig1){ref-type="fig"}). In addition to these fully penetrant lens phenotypes, the neural retina was often observed to aberrantly protrude toward the diminished lens. This observation is consistent with the known role of the properly developed lens in the correct placement of the retina ([Figure 1A](#fig1){ref-type="fig"}, asterisks) ([@bib3]).

During lens development, the transcription factors Pax6 and Prox1 are of vital importance for the normal differentiation of the transparent lens. Pax6 controls lens induction and fate determination while Prox1 regulates fiber cell differentiation and crystallin expression ([@bib3]; [@bib4]). Interestingly, notwithstanding the severe morphological defects including the frequent ventral rotation of the lens epithelial layer, Prox1, Pax6 and multiple forms of crystallin (α,β,γ) were still expressed ([Figure 2A and B](#fig2){ref-type="fig"}). In addition, the polarity of the lens fiber cells was also preserved as evidenced by the localization of Zo-1 and β1 integrin to the apical and basal sides of the lens, respectively ([Figure 2C](#fig2){ref-type="fig"}, arrowheads). However, there were both a reduction in cell proliferation and an increase in apoptosis in the lens epithelial cells as shown by Ki67 and TUNEL staining ([Figure 2D and E](#fig2){ref-type="fig"}, arrowheads), which likely accounted for the diminished lens epithelial layer ([Figure 2A and B](#fig2){ref-type="fig"}, arrowheads). Collectively, these data show that Crk proteins are dispensable for lens differentiation and polarity, but are essential for proliferation, survival and elongation of the cells that make up the structurally mature lens.

![Molecular defects in the *Crk* and *Crkl* double mutant lens.\
(**A**) There were no significant changes in the staining intensity of the lens determinant markers Prox1 and Pax6. (**B**) Further, none of the three forms of Crystallins (α, β, γ) displayed any changes in staining intensity in the CrkCKO lens. (**C**) The polarity of the CrkCKO lens fiber cells was maintained as indicated by both the apical expression of Zo-1 and the basal expression of β1 integrin. (**D**) The number of Ki67-expressing proliferative cells was significantly decreased and the number of TUNEL-positive apoptotic cells was increased (arrowheads). (**E**) Quantification of proliferation and apoptosis in wild type and CrkCKO lens. Student's t test, \*p\<0.01, \*\*p\<0.001, *n* = 4.\
10.7554/eLife.32586.006Figure 2---source data 1.Source data for [Figure 2E](#fig2){ref-type="fig"}.](elife-32586-fig2){#fig2}

Crk proteins act downstream of FGF signaling to control fiber cell elongation {#s2-2}
-----------------------------------------------------------------------------

To investigate the role of Crk proteins in FGF signaling, we took a three-prong approach, combining in vitro, in vivo and ex vivo experiments. First, we performed loss-of-function experiments to examine whether FGF signaling is required for Crk protein activity. Consistent with previous studies showing that FGF signaling is essential for early lens development ([@bib18]), we observed that genetic ablation of Fgfr1/2 in *Pax6^Le^-Cre;Fgfr1^flox/flox^;Fgfr2^floxflox^* (FgfrCKO) mutants disrupted lens vesicle invagination at E10.5 ([Figure 3A](#fig3){ref-type="fig"}). Although the mutant lens cells still expressed Pax6, the lens specific marker αA-crystallin was not induced. Importantly, whereas the control embryos displayed the phosphorylation of Erk and Crk in the invaginating lens vesicle, these staining patterns were absent in FgfrCKO lens cells ([Figure 3A](#fig3){ref-type="fig"}). To further corroborate these results in vitro, we isolated primary mouse embryonic fibroblast (MEF) cells from *Fgfr1^flox/flox^;Fgfr2^floxflox^* embryos and infected them with a Cre-expressing adenovirus to ablate Fgfr1 and Fgfr2. Unlike wild type controls, these mutant MEF cells failed to elevate the level of pCrk/Crkl and pErk upon FGF stimulation, demonstrating that both Crk and Erk proteins are under the tight regulation of FGF signaling ([Figure 3B](#fig3){ref-type="fig"}). To probe the relationship between Crk and Erk, we next infected *Crk^flox/flox^;Crkl^floxflox^* MEF cells with the Cre adenovirus to deplete Crk proteins ([Figure 3C](#fig3){ref-type="fig"}). As a result, both the intensity and duration of FGF-stimulated Erk phosphorylation were down regulated, suggesting that Crk proteins modify the quantity of FGF-ERK signaling by elevating and prolonging ERK activation. Consistent with this, we noticed that Erk phosphorylation was prominent in the elongating primary lens fiber cells at E12.5 and in the transitional zone of the lens at E14.5 ([Figure 3D](#fig3){ref-type="fig"}). In the CrkCKO mutant lens, however, pERK staining was significantly reduced ([Figure 3D](#fig3){ref-type="fig"}). Together, this data shows that Crk proteins regulate FGF-induced Erk activation in the developing lens.

![Crk proteins mediate FGF signaling in Erk phosphorylation.\
(**A**) Genetic ablation of Fgfr1 and Fgfr2 disrupted the proper formation of the lens vesicle with the phosphorylation of Erk and Crk/Crkl proteins being noticeably absent. (**B**) Mouse Embryonic fibroblast (MEF) cells treated with FGF2 displayed an increase in pCrk/Crkl and pErk levels, which were abrogated by the removal of Fgfr1 and Fgfr2 using a Cre-expressing adenovirus. (**C**) Ablation of Crk proteins in MEF cells reduced FGF2-induced Erk phosphorylation. The pErk/Erk ratios were noted below the pERK blot. (**D**) The CrkCKO lens displayed a significant decrease in pERK staining compared to the wild type lens.](elife-32586-fig3){#fig3}

The second approach we took to probe the role of *Crk* genes in FGF signaling was based on gain-of-function experiments. We utilized two *Fgf3* transgenes that are driven by the αA-crystallin promoter to target the lens ([@bib59]), which led to an anterior expansion of pErk staining ([Figure 4C](#fig4){ref-type="fig"}). The *Fgf3^OVE393A^* line displayed excessive elongation of the lens fiber cells that protruded through the corneal epithelium, while the *Fgf3^OVE391^* line showed a more modest enlargement of the lens ([Figure 4A](#fig4){ref-type="fig"}). After crossing these mice with *Crk* mutants, however, lens abnormalities in both lines were suppressed and ectopic phospho-Erk staining was abrogated. The length of the fiber cells was reduced to the same size as those seen in the CrkCKO mutants, demonstrating that *Crk* genes were necessary for the induction of fiber cell elongation by FGF ([Figure 4B](#fig4){ref-type="fig"}). *Fgf3* overexpression also led to premature exiting of the cell cycle as indicated by the loss of the cell proliferation marker Ki67 ([Figure 4C](#fig4){ref-type="fig"}, arrowheads) and an increase in expression of the cell cycle inhibitor p57 ([Figure 4C](#fig4){ref-type="fig"}, arrows). As a result, the anterior lens epithelial cells differentiated prematurely to express the fiber cell markers Jag1 and C-Maf at the expense of the epithelial cell markers E-cadherin and Foxe3. Interestingly, the cell cycle and differentiation abnormalities were not rescued after crossing the *Fgf3* transgenic mice with CrkCKO mutants. These genetic epistasis experiments further highlighted that the specific functionality of *Crk* genes is in mediating FGF signaling for lens cell elongation but not differentiation.

![Crk/Crkl deletion prevented FGF-induced lens cell elongation without affecting differentiation.\
(**A**) Overexpression of *Fgf3* in *Fgf3^OVE391^* and *Fgf3^OVE393A^* strains resulted in increased lens fiber cell elongation and overall lens sizes. However, both of these phenotypes were suppressed after being crossed with the CrkCKO mutant, indicating a genetic epistasis interaction between the FGF and Crk signaling pathways. (**B**) Quantification of lens fiber cell length. One-way ANOVA test followed by Tukey\'s multiple comparisons test, \*p\<0.01, *n* = 3. (**C**) Deletion of the *Crk* genes did not prevent the premature differentiation phenotype observed in the *Fgf3* overexpressing lens, as indicated by a reduction of lens progenitor cell markers (Ki67, E-cad and Foxe3) and an increase of differentiation cell markers (p57, Jag1, and C-Maf) within the presumptive lens epithelial layer (arrows). Nonetheless, pERK staining was significantly reduced in the CrkCKO;*Fgf3^OVE391^* lens. (**D**) The Cre-expressing adenovirus induces efficient genetic recombination in lens explant cultures as indicated by the *ROSA^mTmG^* reporter. In *Crk^flox/flox^;Crkl^floxflox^* explants, the Cre-mediated deletion of Crk proteins prevented Fgf2 from inducing cell shape changes.\
10.7554/eLife.32586.010Figure 4---source data 1.Source data for [Figure 4B](#fig4){ref-type="fig"} and [Figure 7P](#fig7){ref-type="fig"}.](elife-32586-fig4){#fig4}

In the third approach, we used the mouse lens explant system to test the direct role of Crk proteins in FGF-induced fiber cell elongation ([@bib30]). In this assay, the explant lens isolated from P3 mouse embryos carrying *Crk^flox/flox^;Crkl^floxflox^* alleles was infected with a Cre-expressing adenovirus to achieve acute genetic ablation. This avoids any potential complication that may stem from defects in early lens development or other compartments of the eye. Using a *ROSA^mTmG^* mouse line that switches the reporter expression from membrane TdTomato to membrane GFP upon Cre mediated recombination, we showed that a 2 day incubation period with the virus was sufficient to induce genetic changes in all lens epithelial cells ([Figure 4D](#fig4){ref-type="fig"}). In control explants, β-catenin staining revealed a robust elongation of the lens epithelial cells after FGF2 exposure. By contrast, the lens epithelial cells in *Crk^flox/flox^;Crkl^floxflox^* explants treated with the Cre adenovirus retained the epithelial specific hexagonal shape without any obvious signs of elongation. Taken together, these three lines of evidence established that Crk proteins are essential mediators of FGF signaling whose specific function relates to the fiber cell elongation that occurs during lens development.

The Frs2 binding site on Fgfr1 is required for Crk signaling {#s2-3}
------------------------------------------------------------

Previous studies have suggested that Crk proteins bind directly to the phosphorylated tyrosine-463 residue on Fgfr1 to mediate downstream signaling ([@bib32]). Surprisingly, mice carrying a Y463F mutation in *Fgfr1* (*Fgfr1^Crk^*) lacked any observable phenotypes and were reported to be both viable and fertile ([@bib9]). The lack of abnormality in *Fgfr1^CRK^* mice prompted us to examine whether it was due to the compensatory functions of other Fgf receptors. We isolated MEF cells from *Fgfr1^Crk^;Fgfr2^flox^* mice and removed *Fgfr2* by Cre-mediated recombination in vitro. Although we have shown above that genetic inactivation of Fgfr1 and Fgfr2 together was sufficient to abrogate FGF signaling in MEF cells ([Figure 3B](#fig3){ref-type="fig"}), FGF was still able to induce phosphorylation of Crk/Crkl and Erk in *Fgfr1^CRK^* MEF cells after the deletion of *Fgfr2* ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). We next investigated the requirement of the Y463 residue of Fgfr1 for Crk signaling in lens development. For this purpose, we genetically ablated all FGF receptors (*Fgfr2*, *Fgfr3* and *Fgfr4*) with the exception of *Fgfr1* in the mouse lens, resulting in only a modest reduction in lens size ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}). Even in such a stringent genetic background, a homozygous *Fgfr1^Crk^* mutation did not further worsen the lens phenotype or disrupt pCrk staining. These results show that the putative Y463 Crk binding site on Fgfr1 is dispensable for FGF-dependent lens development and Crk signaling.

Since our biochemical and genetic data did not support a functional role for the direct interaction between FGF receptors and the Crk protein, we next explored whether FGF signaling may engage Crk indirectly through intermediaries. Frs2 is a myristylated protein located at the plasma membrane that binds to Fgf receptors specifically at a juxtamembrane site. With multiple tyrosine residues phosphorylated by activated Fgf receptors, Frs2 acts as a nexus of FGF signaling by presenting easily accessible docking sites for the phosphotyrosine-binding proteins Shp2 and Grb2, which in turn activate Ras-MAPK signaling. Taking advantage of a mutant *Fgfr1* allele (*Fgfr1^ΔFrs^*) that lacks the Frs2 binding site ([@bib26]), we showed that formation of the lens vesicle was indeed disrupted in *Pax6^Le^-Cre;Fgfr1^flox/ΔFrs^;Fgfr2^flox/flox^* embryos ([Figure 5A](#fig5){ref-type="fig"}), which resembled the phenotype of FgfrCKO null mutants ([Figure 3A](#fig3){ref-type="fig"}). Importantly, we observed that the loss of the Fgfr-Frs2 interaction also abrogated the phosphorylation of Crk proteins. This was further confirmed in vitro using *Fgfr1^flox/ΔFrs^;Fgfr2^floxflox^* MEF cells infected with a Cre adenovirus. The resulting *Fgfr1^-/ΔFrs^;Fgfr2^-/-^* MEF cells failed to elevate the levels of pERK or pCrk/Crkl in response to FGF2 stimulation ([Figure 5B](#fig5){ref-type="fig"}), demonstrating that the Frs2-binding site on Fgfr1 is necessary for Crk signaling.

![Crk proteins are recruited to the Frs2-Shp2-Grb2 complex in FGF signaling.\
(**A--B**) Mutating the Frs2-bindng site in *Fgfr1^ΔFrs^* resulted in the loss of pCrk/Crkl in the *Pax6^Le^-Cre;Fgfr1^flox/ΔFrs^;Fgfr2^floxflox^* mutant lens. (**B**) FGF2 was unable to induce the phosphorylation of Crk proteins in *Fgfr1^flox/ΔFrs^;Fgfr2^floxflox^* MEF cells after treatment with the Cre expressing adenovirus. (**C**) FGF2-induced pCrk/Crkl and pErk were significantly downregulated in both *Frs2* and *Shp2* null MEF cells. (**D**) Shp2 was successfully depleted in the Frs2CKO;Shp2CKO lens, which resulted in the loss of pCrk/Crkl staining. (**E**) pERK was downregulated in both CrkCKO and Shp2CKO lenses and was further reduced in CrkCKO;Shp2CKO mutants. (**F**) FGF2-induced pCrk/Crkl and pErk were down regulated in *Grb2* deficient MEF cells. (**G**) TAP-taged Crkl pulled down Frs2, Shp2 and Grb2 after FGF2 stimulation. Note that only the slower moving phosphorylated form of Frs2 successfully interacted with Crkl.](elife-32586-fig5){#fig5}

Crk proteins are recruited indirectly to FGF receptors by the Frs2-Shp2-Grb2 complex {#s2-4}
------------------------------------------------------------------------------------

The above results suggested that Frs2 may be the adaptor protein that recruits Crk to Fgf receptors. To test this idea, we first examined Crk phosphorylation in MEF cells that were mutated by the Cre-mediated deletion of *Frs2* and *Shp2*. As shown in [Figure 5C](#fig5){ref-type="fig"}, phosphorylation of Crk proteins induced by FGF was significantly reduced in *Frs2* null MEF cells. Moreover, in MEF cells lacking the Frs2 interacting protein Shp2, even the normally seen basal levels of pCrk were lost. We have previously showed that both Frs2 and its binding partner Shp2 have relatively slow turnover rates in vivo ([@bib33]). As a result, the conditional inactivation of *Frs2* or *Shp2* alone exhibited only a modest lens phenotype. Combined deletion of *Frs2* and *Shp2* in *Le-Cre;Frs2^flox/floxs^;Shp2^floxflox^* (Frs2CKO;Shp2CKO) embryos, however, did block lens development at E14.5. At this stage, the control lens displayed a significant accumulation of Shp2 protein in the transitional zone of the lens, which is also the area of maximum pErk and pCrk/Crkl staining ([Figure 5D](#fig5){ref-type="fig"}, arrows). In contrast, neither Shp2 nor the pCrk/Crkl proteins were detectable in the Frs2CKO;Shp2CKO lens. Notably, an in vitro ablation of either Crk or Shp2 reduced the Erk phosphorylation that is normally induced by FGF ([Figure 3C](#fig3){ref-type="fig"} and [Figure 5D](#fig5){ref-type="fig"}). Consistent with this, both CrkCKO and Shp2CKO embryos at E12.5 continued to display residual levels of pErk staining in the lens ([Figure 5E](#fig5){ref-type="fig"}). In CrkCKO;Shp2CKO mutants, however, pErk staining was entirely abolished, suggesting that Shp2 and the Crk family of proteins act synergistically to regulate Erk signaling.

Grb2 is another binding partner of Frs2 that is essential for the activation of Ras-MAPK signaling. In Grb2-depleted MEF cells, we observed a similar reduction in Crk and Erk signaling in response to FGF stimulation ([Figure 5F](#fig5){ref-type="fig"}). The attenuation of Crk phosphorylation in *Frs2*, *Shp2* and *Grb2* deficient cells raises the possibility that Crk proteins are recruited to the Fgf receptors via the Frs2-Shp2-Grb2 complex. To probe the physical interaction between these proteins, we transfected NIH-3T3 cells with a TAP-Crkl construct that encodes the Crkl protein conjugated to a tandem affinity purification (TAP) tag used for purification ([@bib23]). When the concentration of FGF was increased, we observed a shift of Frs2 mobility in our immunoblot analysis that is representative of the phosphorylated form of Frs2 being generated as has been previously reported ([Figure 5G](#fig5){ref-type="fig"}) ([@bib31]). Consistent with this, there was also an increase in the levels of pErk present in the cell lysates. Interestingly, immunoprecipitated TAP-Crkl only pulled down the phosphorylated form of Frs2 induced by FGF stimulation, which was also accompanied by Shp2 and Grb2. Overall these results indicate that the Frs2-Shp2-Grb2 complex is responsible for recruiting Crk proteins to the activated Fgf receptor.

Rac1 is a downstream effector of crk proteins in lens fiber cell elongation {#s2-5}
---------------------------------------------------------------------------

Crk proteins have been implicated in the activation of the small molecular GTPases Rac1 and Rap1, which play important roles in cell adhesion, cytoskeletal rearrangement and cell shape changes ([@bib8]; [@bib17]). Previous studies have reported that the conditional deletion of Rac1 in the lens resulted in impaired actin polymerization that lead to a morphologically impaired lens ([@bib39]). Since *Rac2* has also been reported to be expressed in the lens ([@bib55]), we decided to inactivate both *Rac1* and *Rac2* to compare their phonotype with that of the *Crk* mutants. Immunofluorescence confirmed the specific depletion of Rac1 in the *Pax6^Le^-Cre;Rac1^flox/flox^;Rac2^-/-^* (RacCKO) lens ([Figure 6A--B](#fig6){ref-type="fig"}). Unlike the CrkCKO lens, however, the RacCKO lens did not display a decrease in pErk staining ([Figure 6C--D](#fig6){ref-type="fig"}). Nonetheless, depletion of Rac proteins resulted in a lens fiber cell elongation defect, albeit milder than that seen in the CrkCKO lens ([Figure 6E--G](#fig6){ref-type="fig"}). To further explore the relationship between Rac and Crk proteins, we utilized the *R26-Rac1^LSL-G12V^* allele that results in the expression of a constitutively active form of Rac1 (Rac1CA) after the Cre mediated excision of its STOP cassette ([@bib65]). In the *Pax6^Le^-Cre;Crk^flox/flox^;Crkl^floxflox^;R26-Rac1^LSL-G12V^* (CrkCKO;Rac1CA) lens, there was a statistically significant increase in fiber cell length as compared to that of the CrkCKO lens ([Figure 6H and U](#fig6){ref-type="fig"}). The partial rescue of the CrkCKO phenotype by Rac1 activation supports the idea that Rac1 is a downstream effector of Crk in the signaling pathways that lead to lens fiber cell elongation.

![Rac proteins are downstream effectors of Crk signaling.\
(**A--D**) Staining of Rac-depleted lenses with a pErk antibody showed no significant difference in staining intensity. (**E--H**) Phalloidin (F-actin) staining revealed that the length of lens fiber cells (indicated by arrows) was significantly reduced in CrkCKO and RacCKO lenses, which was partially reversed after the activation of Rac signaling in CrkCKO;Rac1CA lenses. (**I--N**) The Rap1 depleted mutants displayed a detachment of the lens fiber cells from the anterior side of the lens epithelial cells (arrow) and Smooth Muscle Actin (SMA) staining within the lens epithelial layer itself (arrowheads). These phenotypes were absent both in the control and the Crk/Crkl depleted lenses. (**O--T**) Immunstaining of the Rac and Rap1 depleted lenses with progentior (Foxe3, E-cad, Ki67) and differentiation (C-Maf, Jag1,p57) markers did not reveal any defects in differentiation or any further shortening of the fiber cells. (**I**) Quantification of fiber cell lengths. One-way ANOVA test followed by Tukey\'s multiple comparisons test, \*p\<0.01, *n* = 3.\
10.7554/eLife.32586.013Figure 6---source data 1.Source data for [Figure 6U](#fig6){ref-type="fig"}.](elife-32586-fig6){#fig6}

Rap1 is also known to be targeted by Crk proteins via activation of the guanine nucleotide exchange factor (GEF), C3G, and FGFR1 has previously been reported to activate Rap1 in endothelial cells ([@bib54]; [@bib75]). We reasoned that if Rap1 was a downstream effector of Crk proteins in FGF signaling, *Rap1* and *Crk* deficient lenses should phenocopy each other as well. In agreement with a previous report ([@bib40]), we found that the conditional knockout of two *Rap1* genes (*Pax6^Le^-Cre;Rap1a^flox/flox^;Rap1b^flox/flox^* (Rap1CKO)) disrupted the epithelial polarity of the lens, leading to an ectopic expression of the epithelial-mesenchymal-transition (EMT) marker smooth muscle actin (SMA) in lens epithelium cells ([Figure 6I--L](#fig6){ref-type="fig"}). Due to cell adhesion defects, the posterior lens fiber cells also failed to remain attached to the anterior epithelial cells as is represented by a noticeable gap in the anterior part of the lens. In contrast, neither of these phenotypes were observed in the CrkCKO mutant lens ([Figure 6M and N](#fig6){ref-type="fig"}), which instead displayed a more severe lens fiber cell elongation defect than the Rap1CKO mutants. We also considered the possibility that *Rap1* and *Rac* may be functionally redundant in the developing ocular lens. The combined deletion of these four genes in *Le-Cre;Rac1^flox/flox^;Rac2^-/-^;Rap1a^flox/flox^;Rap1b^flox/flox^* (RacCKO;Rap1CKO) embryos, however, did not produce any lens differentiation abnormalities or enhance the fiber cell elongation defects previously observed in the RacCKO mutants ([Figure 6O--U](#fig6){ref-type="fig"}). Taken together, these results argue against the Rap1 family of proteins being downstream targets of Crk signaling during lens development.

Activation of ras signaling ameliorated lens fiber cell elongation defects present in the *Crk* mutant {#s2-6}
------------------------------------------------------------------------------------------------------

The above experiments showed that a constitutively active form of Rac1 resulted in only modest attenuation of the lens fiber cell elongation defects seen in the CrkCKO mutant, suggesting that there exist additional downstream effectors of the Crk proteins that are important in regulating fiber cell shape. As we have observed a significant downregulation of pErk in the CrkCKO mutant lens, one potential candidate is the Ras-MAPK signaling pathway. We subsequently crossed the CrkCKO mutant with a *Kras^LSL-G12D^* mouse, which harbors a Cre-inducible allele of the oncogenic G12D mutated *Kras* ([@bib71]). Because this mutant is expressed from the endogenous *Kras* locus, it is expected to activate Ras signaling at a normal physiological level as opposed to being overexpressed. Consistent with this, we observed a modest increase in pERK staining in the *Pax6^Le^-Cre*;*Crk^flox/flox^;Crkl^flox/flox^;Kras^LSL-G12D^* (CrkCKO;*Kras^G12D^*) lens ([Figure 7A--C](#fig7){ref-type="fig"}). Although TUNEL staining showed that the cell apoptosis defect was not rescued in the CrkCKO; *Kras^G12D^* lens, the number of proliferative Ki67 positive cells increased significantly, which can likely explain the extension of the lens epithelium as evidenced by E-cadherin staining ([Figure 7D--L](#fig7){ref-type="fig"}). Importantly, the length of the lens fiber cells in the CrkCKO;*Kras^G12D^* lens increased to about 90% of that of the control lens, demonstrating that the activation of Ras signaling can largely rescue the fiber elongation defects caused by the loss of Crk proteins ([Figure 7M--P](#fig7){ref-type="fig"}). This result provides strong genetic evidence that Ras signaling plays an essential role in Crk-mediated lens cell shape changes.

![Constitutive Kras signaling can compensate for the loss of Crk and Crkl in lens development.\
(**A--C**) Despite the loss of Crk and Crkl, Erk phosphorylation was partially recovered in CrkCKO;*Kras^G12D^* lenses. (**D--F**) A signficant amount of TUNEL positive cells remained in both CrkCKO and CrkCKO;*Kras^G12D^* lenses. (**G--L**) Cell proliferation indicated by Ki57 increased in the CrkCKO;*Kras^G12D^* lens as compared to the CrkCKO lens, but there was no significant difference in staining intensity for the differentiation markers E-cad and Jag1. (**M--P**) Lens fiber cell length increased significantly in CrkCKO;*Kras^G12D^* lenses as compared to CrkCKO ones. Fiber cell length was measured based on F-actin staining and statistical analysis was performed using the one-way ANOVA test followed by Tukey\'s multiple comparisons test (\*p\<0.01, *n* = 3). (**Q**) Model of Crk function in FGF signaling. The binding of FGF to its receptor induces the assembly of the Frs2-Shp2-Grb2 complex, which subsequently activates Ras signaling to promote lens differentiation. When FGF signaling is further elevated at the transitional zone of the lens, Crk proteins were additionally recruited by the Frs2-Shp2-Grb2 complex to further promote Ras and Rac signaling, resulting in actin cytoskeletal rearrangement and cell shape changes.](elife-32586-fig7){#fig7}

Discussion {#s3}
==========

The ocular lens is derived from a single cell type that undergoes an orderly set of successive differentiation change that are represented by various cell shape alterations occurring along the developmental timeline. This makes it an excellent model for studying the cell signaling pathways involved in these morphological processes. Although FGF signaling is known to regulate both lens fiber cell differentiation and elongation, it is unclear whether these two functions can be separated at the mechanistic level. In this study, we successfully showed that the Crk family of adaptor proteins specifically mediate FGF signaling in the control of lens cell shape but not differentiation. Contrary to previous claims, we demonstrated that the putative Crk binding site on Fgfr1 is dispensable. Rather, the recruitment of Crk proteins to the Frs2-Shp2-Grb2 complex via the Frs2 docking site on Fgf receptors was observed. Our study further showed that the downstream Crk effectors involved in regulating the precise cytoarchitecture of the lens are primarily Ras and to a lesser extent Rac1, but not Rap1 ([Figure 7Q](#fig7){ref-type="fig"}). These results identify Crk proteins as the essential adapters that link FGF signaling to cytoskeletal dynamics.

This study also demonstrated that Crk and Crkl play essential overlapping functions in embryonic lens development. Whereas lack of either Crk or Crkl did not disrupt lens development in the mouse embryos, combined deletion of Crk and Crkl led to a profound defect in lens fiber cell elongation. There is a substantial overlap between Crk and Crkl in many biological functions including the Reelin pathway ([@bib50]), neuromuscular synapse formation ([@bib24]), migration of T cells to sites of inflammation ([@bib27]) and podocyte morphogenesis ([@bib19]). These studies and ours confirm that single and double floxed mice for Crk and Crkl are crucial models for investigating the distinct and overlapping biological functions of these closely related proteins.

Crk and Crkl are versatile adaptor proteins that can interact with a wide spectrum of signaling molecules ([@bib8]). Previous studies have shown that they can be recruited by molecular scaffolds such as Dab1 to transmit Reelin signaling or p130Cas and paxillin to participate in integrin signaling ([@bib45]; [@bib52]; [@bib62]). Following growth factor stimulation, Crk and Crkl are also known to bind directly to several receptor tyrosine kinases (RTKs) via their SH2 domains and become rapidly phosphorylated at their specifically targeted tyrosine residues (Y221 in Crk and Y207 in Crkl) ([@bib2]; [@bib16]). Upon ligand stimulation, FGF receptors undergo autophosphorylation at multiple tyrosine residues, which serve as docking sites for downstream signaling proteins. Previous studies have suggested that Crk and Crkl can recognize a conserved phosphotyrosine residue in FGFRs (pY463 in FGFR1 and pY466 in FGFR2) through their SH2 domains ([@bib32]). By examining the Y463F mutant of Fgfr1 both in vitro and in vivo, we showed that this site was dispensable for FGF signaling with regards to the activation of Crk proteins. By contrast, we showed that Crk proteins interact with Frs2 and Shp2 proteins, and that their loss prevents FGF-induced Crk phosphorylation. This is reminiscent of Frs2's function in response to nerve growth factor (NGF) to assemble a complex containing Crk, C3G, Rap1 and Braf in order to prolong MAPK signaling ([@bib28]). Interestingly, in that case, the binding of Crk requires the Shp2-docking site on Frs2. We have also identified Grb2 as yet another interacting partner of Crkl and showed that Grb2 was required for FGF-induced phosphorylation of Crk and Crkl. Since both Frs2 and Shp2 interact with Grb2, we would like to suggest that the assembly of the entire Frs2-Shp2-Grb2 complex is necessary for the recruitment of the Crk family of adaptor proteins to Fgf receptors.

C3G, Sos and Dock1 were the first three GEFs identified to be directly associated with the SH3 domains of Crk ([@bib25]; [@bib46]; [@bib68]). While Sos is primarily involved in the activation of Ras-MAPK signaling, C3G and Dock1 promote the exchange of GDP for GTP in the small GTPases Rap1 and Rac1 ([@bib8]). These active GTP-bound proteins subsequently regulate integrin signaling and actin polymerization ([@bib20]; [@bib56]). We showed that the *Crk* knockout did not recapitulate the *Rap1* mutant lens phenotype, ruling out Rap1 as a critical downstream effector of Crk proteins. Instead, activation of Rac1 and, more importantly, Ras effectively rescued the lens fiber elongation defect seen in *Crk* mutants. In addition to these results further clarifying the downstream targets of Crk in lens development, they also raise an interesting question regarding the nature of Ras signaling in this process. Previous studies have shown that the Frs2/Shp2 mediated Ras-MAPK pathway acts downstream of FGF signaling to regulate lens fiber cell differentiation ([@bib33]; [@bib38]; [@bib72]), but in this study, our genetic evidence demonstrated that the Crk-mediated Ras signaling pathway only promoted fiber cell elongation and not differentiation. The uncoupling of lens fiber cell differentiation and elongation have been previously observed in lens explants, where pharmacological inhibition of ERK suppressed the morphological changes induced by FGF signaling while not preventing the expression of differentiation markers such as β-crystallin ([@bib37]). We propose that these results reveal a biphasic function of Ras signaling, which promotes either differentiation or elongation of lens cells in a dosage dependent manner. In this model, Ras signaling induced directly by the Frs2/Shp2/Grb2 complex is sufficient to stimulate cell differentiation, with the additional elevation of Ras activity potentiated by the binding of Crk proteins to the signaling complex resulting in the necessary promotion of cell shape changes. In support of this idea, we note that the loss of Crk proteins did not completely squelch Ras-MAPK signaling, allowing cell differentiation to proceed in *Crk* mutant lenses. Therefore, in response to heightened FGF signaling, Crk proteins act as additional boosters to Ras activity that results in the specific promotion of cell shape changes.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\               Designation                                     Source or reference                                 Identifiers                                                                  Additional information
  or resource                                                                                                                                                                                                            
  ------------------------------------- ----------------------------------------------- --------------------------------------------------- ---------------------------------------------------------------------------- ------------------------------------------------------------------------------------
  Genetic reagent (*M. musculus*)       *Crk^flox^, CrkL^flox^*                         PMID: 19074029                                      RRID:[MGI:3830069](https://scicrunch.org/resolver/MGI:3830069)               Dr. Tom Curran (The Children\'s Research Institute, Children\'s Mercy Kansas City)

  Genetic reagent (*M. musculus*)       *Fgfr3^flox^*                                   PMID: 20582225                                      RRID:[MGI:4459834](https://scicrunch.org/resolver/MGI:4459834)               Dr. Xin Sun (University of California San Diego)

  Genetic reagent (*M. musculus*)       *Frs2α^flox^*                                   PMID: 17868091                                      RRID:[MGI:3768915](https://scicrunch.org/resolver/MGI:3768915)               Dr. Feng Wang (Texas A and M)

  Genetic reagent (*M. musculus*)       *Rap1a^flox^, Rap1b^flox^*                      PMID: 18305243                                      RRID:[MGI:3777607](https://scicrunch.org/resolver/MGI:3777607)               Alexei Morozov (National Institutes of Health)

  Genetic reagent (*M. musculus*)       *Shp2^flox^*                                    PMID: 15520383                                      RRID:[MGI:3522138](https://scicrunch.org/resolver/MGI:3522138)               Gen-Sheng Feng (UCSD)

  Genetic reagent (*M. musculus*)       *Fgf3^OVE391^*                                  PMID: 7539358                                                                                                                    Dr. Michael Robinson (Miami University)

  Genetic reagent (*M. musculus*)       *Fgf3^OVE393A^*                                 PMID: 9640329                                                                                                                    Dr. Michael Robinson (Miami University)

  Genetic reagent (*M. musculus*)       *Fgfr1*^Δ*Frs*^                                 PMID: 16421190                                      RRID:[MGI:3620075](https://scicrunch.org/resolver/MGI:3620075)               Dr. Raj Ladher (RIKEN Kobe Institute-Center for Developmental Biology)

  Genetic reagent (*M. musculus*)       *Fgfr1^Crk^*                                    PMID: 26341559                                      RRID:[MGI:5882534](https://scicrunch.org/resolver/MGI:5882534)               Dr. Philipo Soriano (Washington University Medical School)

  Genetic reagent (*M. musculus*)       *Fgfr2^flox^*                                   PMID: 12756187                                      RRID:[MGI:3044690](https://scicrunch.org/resolver/MGI:3044690)               Dr. David Ornitz (Washington University Medical School)

  Genetic reagent (*M. musculus*)       *Fgfr4^-/-^*                                    PMID: 9716527                                       RRID:[MGI:3653043](https://scicrunch.org/resolver/MGI:3653043)               Dr. Chu-Xia Deng (National Institute of Health)

  Genetic reagent (*M. musculus*)       *Grb2^flox^*                                    PMID: 21427701                                      RRID:[MGI:4949890](https://scicrunch.org/resolver/MGI:4949890)               Dr. Lars Nitschke (University of Erlangen-Nürnberg)

  Genetic reagent (*M. musculus*)       *Pax6^Le^-Cre* (*Le-Cre*)                       PMID: 11069887                                      RRID:[MGI:3045795](https://scicrunch.org/resolver/MGI:3045795)               Dr. Ruth Ashery-Padan (Tel Aviv University)

  Genetic reagent (*M. musculus*)       *Rac1^flox^*                                    PMID: 12759446                                      RRID:[MGI:2663672](https://scicrunch.org/resolver/MGI:2663672)               Dr. Feng-Chun Yang (Indiana University School of Medicine)

  Genetic reagent (*M. musculus*)       *Rac2^-/-^*                                     PMID: 10072071                                      RRID:[MGI:3840460](https://scicrunch.org/resolver/MGI:3840460)               Dr. Feng-Chun Yang (Indiana University School of Medicine)

  Genetic reagent (*M. musculus*)       *Kras^LSL-G12D^*                                PMID: 15093544                                      RRID:[MGI:3044567](https://scicrunch.org/resolver/MGI:3044567)               Mouse Models of Human Cancers Consortium Repository at National Cancer Institute

  Genetic reagent (*M. musculus*)       *Fgfr1^flox^*                                   Jackson Laboratory                                  Stock \#: 007671\                                                            PMID:16421190
                                                                                                                                            RRID:[MGI:3713779](https://scicrunch.org/resolver/MGI:3713779)               

  Genetic reagent (*M. musculus*)       *R26-Rac1^LSL-G12V^*                            Jackson Laboratory                                  Stock \#: 012361\                                                            PMID:19879843
                                                                                                                                            RRID:[MGI:4430563](https://scicrunch.org/resolver/MGI:4430563)               

  Genetic reagent (*M. musculus*)       *ROSA^mTmG^*                                    Jackson Laboratory                                  Stock \#: 007676\                                                            PMID:17868096
                                                                                                                                            RRID:[MGI:3722405](https://scicrunch.org/resolver/MGI:3722405)               

  Cell line(*M. musculus*)              NIH-3T3                                         American Type Culture Collection                    Cat\# CRL-1658, RRID:[CVCL_0594](https://scicrunch.org/resolver/CVCL_0594)   

  Transfected construct (synthesized)   TAP-CrkL                                        PMID: 26527617                                                                                                                   David J. Glass

  Antibody                              Rabbit anti-C-maf                               Santa Cruz Biotechnology                            Cat. \#: sc-7866\                                                            IHC (1:200)
                                                                                                                                            RRID: [AB_638562](https://scicrunch.org/resolver/AB_638562)                  

  Antibody                              Rabbit anti-CrkL                                Santa Cruz Biotechnology                            Cat. \#: sc-319\                                                             IHC (1:100), WB (1:1000)
                                                                                                                                            RRID: [AB_631320](https://scicrunch.org/resolver/AB_631320)                  

  Antibody                              Mouse anti-CrkL                                 Santa Cruz Biotechnology                            Cat. \#: sc-365471                                                           WB (1:1000)

  Antibody                              Mouse anti-E-cadherin                           Sigma                                               Cat. \#: U3254                                                               IHC (1:200)

  Antibody                              Rabbit anti-Frs2                                Santa Cruz Biotechnology                            Cat. \#: sc-8318\                                                            WB (1:1000)
                                                                                                                                            RRID: [AB_2106228](https://scicrunch.org/resolver/AB_2106228)                

  Antibody                              Rabbit anti-Grb2                                Santa Cruz Biotechnology                            Cat. \#: sc-255\                                                             WB (1:1000)
                                                                                                                                            RRID: [AB_631602](https://scicrunch.org/resolver/AB_631602)                  

  Antibody                              Rabbit anti-Jag1                                Santa Cruz Biotechnology                            Cat. \#: sc-6011\                                                            IHC (1:100)
                                                                                                                                            RRID: [AB_649689](https://scicrunch.org/resolver/AB_649689)                  

  Antibody                              Mouse anti-Ki-67                                BD Pharmingen                                       Cat. \#: 550609\                                                             IHC (1:200)
                                                                                                                                            RRID: [AB_393778](https://scicrunch.org/resolver/AB_393778)                  

  Antibody                              Rabbit anti-p57                                 Abcam                                               Cat. \#: ab75974                                                             IHC (1:2000)

  Antibody                              Rabbit anti-Pax6                                Covance                                             Cat. \#: PRB-278P\                                                           IHC (1:500)
                                                                                                                                            RRID: [AB_291612](https://scicrunch.org/resolver/AB_291612)                  

  Antibody                              Rabbit anti-pCrk (Tyr221)                       Cell Signaling                                      Cat. \#: 3491                                                                IHC (1:200), WB (1:1000)

  Antibody                              Rabbit anti-pCrkL (Tyr207)                      Cell Signaling                                      Cat. \#: 3181                                                                WB (1:1000)

  Antibody                              Rabbit anti-pERK1/2                             Cell Signaling                                      Cat. \#: 4370                                                                IHC (1:200), WB (1:1000)

  Antibody                              Mouse anti-pERK1/2                              Santa Cruz Biotechnology                            Cat. \#: sc-7383                                                             WB (1:1000)

  Antibody                              Rabbit anti-Prox1                               Covance                                             Cat. No.: PRB-238C                                                           IHC (1:1000)

  Antibody                              Mouse anti-Rac1                                 BD Transduction Laboratory                          Cat. \#: 610652\                                                             IHC (1:200)
                                                                                                                                            RRID: [AB_397979](https://scicrunch.org/resolver/AB_397979)                  

  Antibody                              Rabbit anti-Shp2                                Santa Cruz Biotechnology                            Cat. \#: sc-280\                                                             IHC (1:100), WB (1:1000)
                                                                                                                                            RRID: [AB_632401](https://scicrunch.org/resolver/AB_632401)                  

  Antibody                              Rabbit anti-α-crystallin                        Sam Zigler (National Eye Institute)                                                                                              IHC (1:5000)

  Antibody                              Mouse anti-α-SMA                                Sigma                                               Cat. \#: C6198                                                               IHC (1:1000)

  Antibody                              Mouse anti-β-catenin                            Sigma                                               Cat. \#: 6F9                                                                 IHC (1:200)

  Antibody                              Rabbit anti-β-crystallin                        Sam Zigler (National Eye Institute)                                                                                              IHC (1:5000)

  Antibody                              Rabbit anti-γ-crystallin                        Sam Zigler (National Eye Institute)                                                                                              IHC (1:5000)

  Recombinant DNA reagent               Ad5CMVCre-eGFP                                  Gene Transfer Vector Core, University of Iowa, IA   VVC-U of Iowa-1174                                                           

  Recombinant DNA reagent               Ad5CMVeGFP                                      Gene Transfer Vector Core, University of Iowa, IA   VVC-U of Iowa-4                                                              

  Peptide, recombinant protein          recombinant human FGF2                          ScienCell                                           104--02                                                                      

  Peptide, recombinant protein          recombinant murine FGF2                         ScienCell                                           124--02                                                                      

  Commercial assay or kit               In situ cell death detection kit, Fluorescein   Sigma                                               11684795910 ROCHE                                                            

  Commercial assay or kit               streptavidin resin                              Agilent                                             240207                                                                       

  Chemical compound, drug               Alexa Fluor 488 Phalloidin                      ThermoFisher Scientific                             A12379                                                                       1:50

  Chemical compound, drug               heparin sodium                                  Sigma                                               H3393                                                                        
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mice {#s4-1}
----

Mice carrying *Crk^flox^, Crkl^flox^*, *Fgfr3^flox^, Frs2α^flox^*, *Rap1a^flox^, Rap1b^flox^* and *Shp2^flox^* alleles were bred and genotyped as described ([@bib34]; [@bib47]; [@bib50]; [@bib66]; [@bib77]). *Fgf3^OVE391^* and *Fgf3^OVE393A^* were from Dr. Michael Robinson (Miami University, Oxford, OH), *Fgfr1^ΔFrs^* from Dr. Raj Ladher (RIKEN Kobe Institute-Center for Developmental Biology, Kobe, Japan), *Fgfr1^Crk^* from Dr. Philipo Soriano (Washington University Medical School, St Louis, MO), *Fgfr2^flox^* from Dr. David Ornitz (Washington University Medical School, St Louis, MO), *Fgfr3^flox^* from Dr. Xin Sun (University of California San Diego, La Jolla, CA), *Fgfr4^-/-^* from Dr. Chu-Xia Deng (National Institute of Health, Bethesda, MD), *Grb2^flox^* from Dr. Lars Nitschke (University of Erlangen-Nürnberg, Erlangen, Germany), *Pax6^Le^-Cre* (*Le-Cre*) from Drs. Ruth Ashery-Padan (Tel Aviv University, Tel Aviv, Israel) and Richard Lang (Children\'s Hospital Research Foundation, Cincinnati, OH), *Rac1^flox^* and *Rac2^-/-^* from Dr. Feng-Chun Yang (Indiana University School of Medicine, Indianapolis, IN) ([@bib1]; [@bib3]; [@bib9]; [@bib21]; [@bib26]; [@bib58]; [@bib59]; [@bib74]; [@bib76]). *Kras^LSL-G12D^* mice were obtained from the Mouse Models of Human Cancers Consortium (MMHCC) Repository at National Cancer Institute ([@bib71]). *Fgfr1^flox^* (Stock No: 007671), *R26-Rac1^LSL-G12V^* (Stock No: 012361) and *ROSA^mTmG^* (Stock No: 007676) mice were obtained from Jackson Laboratory ([@bib26]; [@bib44]; [@bib65]). In all conditional knockout experiments, mice were maintained on a mixed genetic background and at least three animals were analyzed for each genotype ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). We did not observe phenotypic variation in lens development among *Pax6^Le^-Cre* and *Pax6^Le^-Cre;Crk^floxl+^;Crkl^flox/+^* mice, and thus *Pax6^Le^-Cre* only mice were used as controls. Mouse maintenance and experimentation was performed according to protocols approved by Columbia University Institutional Animal Care and Use Committee.

Histology, Immunohistochemistry, Immunocytochemistry {#s4-2}
----------------------------------------------------

Mouse embryos were fixed with 4% paraformaldehyde (PFA) in PBS overnight and paraffin or cryo embedded. The paraffin sections (10 µm) were rehydrated and stained with hematoxylin and eosin (H and E) for histological analysis. Lens sizes were measured as previously described ([@bib11]; [@bib48]). TUNEL staining and immunostaining were performed on the cryosections (8 µm) as previously described ([@bib12]; [@bib13]). For phospho-ERK and Shp2 staining, the signal was amplified using a Tyramide Signal Amplification kit (TSA Plus System, PerkinElmer Life Sciences, Waltham, MA). Antibodies used were: anti-Shp2 (Sc-280), anti-C-maf (sc-7866), anti-Crkl (Sc-319), anti-Jag1 (Sc-6011) (all from Santa Cruz Biotechnology, Santa Cruz, CA), anti-pCrkl (Tyr207) (\#3181, also recognize pCrk (Tyr221) and anti-pERK1/2 (\#4370) (both from Cell Signaling Technology, Boston, MA), anti-P57 (ab75974, from Abcam, Boston, MA), anti-α-SMA (\#C6198), anti-β-catenin (6F9), anti-E-cadherin (U3254) (all from Sigma, St. Louis, MO), anti-Ki67 (\#550609, BD Pharmingen, San Jose, CA), anti-Crk (\#610036), anti-Rac1 (\#610651) (both from BD Transduction Laboratory, Franklin Lakes, NJ), anti-Prox1 (PRB-238C) and anti-Pax6 (PRB-278P) (both from Covance, San Diego, CA). Antibodies against α-, β- and γ-crystallins were kindly provided by Sam Zigler (National Eye Institute). Cell proliferation and apoptosis were measured as the ratio of Ki67 or TUNEL-positive cells versus DAPI-positive cells, and analyzed by one-way ANOVA analysis. Alexa Fluor 488 Phalloidin (A12379, ThermoFisher) was used to stain F-actin.

Lens epithelium explant culture {#s4-3}
-------------------------------

Postnatal day 0 to day 3 *Crk^flox/flox^;Crkl^floxflox^* mice were sacrificed and eyes enucleated. Lenses were then dissected out in lens explant culture medium containing DMEM with 1% BSA (BP1600, Fisher Scientific) and 1:100 dilution of Antibiotic-Antimycotic (15240062, ThermoFisher). Lens capsules were torn open from the posterior before the lens epithelium was peeled off with forceps and pinned down onto a cell culture dish. To delete Crk and Crkl in the lens explants, 2 × 10^7^ adenoviruses expressing Cre recombinase (Ad5CMVCre-eGFP, Cat \#: VVC-U of Iowa-1174, Gene Transfer Vector Core, University of Iowa, IA) were added to the culture of 4 explants for 8 hr one day after explant isolation. GFP-expressing adenoviruses (Ad5CMVeGFP, Cat \#: VVC-U of Iowa-4) were used as a control. To induce fiber cell differentiation and elongation, these explants were further cultured in the lens explant culture medium with 2 mg/ml heparin sodium (H3393, Sigma) and 100 ng/ml recombinant murine FGF2 (124--02, ScienCell, Carlsbad, CA ) for 4--5 days.

Cell protein extract isolation and western blots {#s4-4}
------------------------------------------------

4.24--6.36 × 10^5^ MEF cells infected with Ad5CMVCre were seeded in 60 mm dishes and serum starved (0.5% FBS in DMEM) for 36--48 hr before being stimulated by 50 ng/ml FGF2 (R and D Systems, Minneapolis, MN) for 5 min at 37°C as previously described ([@bib33]). After washing twice in cold PBS, MEF cells were lysed in 160 µl RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 µg/ml aprotinin, 1 µg/ml pepstatin, 10 mM sodium pyrophosphate, 1 mM PMSF, 0.2 mM Na~3~VO~4~, 50 mM NaF). Proteins were visualized by infrared-based western blot analysis using an Odyssey SA scanner (LICOR Biosciences, Lincoln, NE). The signal intensity was quantified using the Odyssey software. The antibodies used were mouse anti-phospho-ERK1/2 (sc-7383, Santa Cruz Biotechnology), anti-phospho-Crk (tyr221) (\#3491, Cell Signaling Technology), rabbit-anti-Crkl (sc-319, Santa Cruz biotechnology), mouse-anti-Crkl (sc-365471, Santa Cruz biotechnology), anti-Shp2 (sc-280, Santa Cruz biotechnology), anti-Grb2 (sc-255, Santa Cruz biotechnology), and anti-Frs2 (sc-8318, Santa Cruz biotechnology).

Immunoprecipitation {#s4-5}
-------------------

NIH3T3 cells from the American Type Culture Collection were tested mycoplasma-free. They were plated at 1 × 10^6^ cell per 10 cm tissue culture plate and transfected with 2.5 μg TAP-Crkl plasmid ([@bib23]) using lipofectamine 3000 (ThermoFisher, Springfield Township, NJ). 36 hr after the transfection, cells were serum depleted overnight and then were treated with 100 ng/ml recombinant human FGF2 (104--02, ScienCell) for 5 min. Both the treatment group and control were lysed with 1 ml immunoprecipitation buffer (25 mM Tris-HCl, pH 7.4, 1 mM EDTA, 150 mM NaCl, 1% NP-40, 5% glycerol) supplemented with Halt protease inhibitor cocktail (ThermoFisher). Lysates were then incubated with streptavidin resins (240207, Agilent, Santa Clara, CA) to pull down TAP-Crkl, according to manufacturer's recommendations. Resins were later washed in streptavidin binding buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl) twice at 4°C. All pulled-down proteins were eluted in 1X Laemmli SDS sample buffer (1.5% SDS, 9% glycerol, 62.5 mM Tris-HCl, pH 6.8, 0.00025% Bromophenol blue, 2% β-mercaptoethanol). Samples were denatured at 95°C for 5 min before being loaded onto SDS-PAGE gels.
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Thank you for submitting your article \"Crk proteins transduce FGF signaling to promote lens fiber cell elongation\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Fiona Watt as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Mark Lewandoski (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers thought that your manuscript utilizes sophisticated genetics and biochemistry to reveal the components and interactions downstream of FGF signaling during the morphogenesis of the mouse lens. They felt that your work has important implications for how molecular signaling controls cell shape. Furthermore, the experiments were described as well executed and the findings as very interesting. The reviewers describe concerns that should be addressed before publication as detailed below.

Essential revisions:

1\) There were concerns that \"Le-Cre only mice were used as controls.\" It is important to have Le-Cre in the controls, because Le-Cre itself can have an effect on eye development (PLoS One. 2014 Oct 1;9(10):e109193). But it is also important that littermates are used as controls to rule out differences due to genetic background affecting phenotypes (and the Le-Cre alone effect is background dependent!). This is a big problem as the authors would have to repeat a lot of experiments. Short of doing that work, perhaps the authors can argue that there was little or no variation in phenotypes? Thus the authors should mention how many samples were examined (hopefully at least three) and mention somewhere what variation was observed. It might also help to include a table listing all the genetic crosses, with parental genotypes and the important experimental progeny.

2\) Some other histological phenotypes in the Crk/L-cKO mutants are not adequately described. For example, the lens epithelial layer appears missing ([Figure 2H, J, L, N, P](#fig2){ref-type="fig"}). Also, there is an abnormal optic cub protrusion posterior to the lens vesicle in Crk/L-cKO mutants. The authors need to describe these phenotypes in more detail, and explain how these phenotypes are affected in other mutant backgrounds. If the lens epithelium is indeed disrupted, could this phenotype affect the maintenance of the polarity of primary fibers and the generation of secondary lens fibers? Also, given the lens-specific deletion of Crk/L, why does the mutation cause the abnormality in the optic cup?

3\) The authors emphasize the co-expression of the pCrk/L and pERK in the transitional zone, where proliferation and differentiation of secondary lens fibers occurs, at E14.5. However, the Crk/L-cKO lens phenotype appears between E10.5 and E12.5. The authors should compare the pCrk/L and pER expression at these earlier stages to strengthen their argument.

4). In [Figure 3C](#fig3){ref-type="fig"}, it appears that the loss of Crk/L mainly affects the substantiation of pERK after FGF2 treatment. Quantification of the western blotting should be very informative here. It would be interesting that Crk/L modify the quantity of FGF-ERK signaling by prolonging ERK activation.

5\) \"Despite the severe morphological defects, Prox1, Pax6 and multiple forms of crystallin (α,β,γ) were expressed without delay ([Figure 2A-N](#fig2){ref-type="fig"}).\" The provided data do not demonstrate the normal onset of Pax6. The authors need to modify the statement or provide additional data to support the statement. Also, authors should indicate that the Pax6+ lens epithelium is greatly reduced and shifted to the ventral position in the mutant.

6\) [Figure 6H](#fig6){ref-type="fig"}, the authors should provide quantitative data to demonstrate the partial rescue of the Crk/L-cKO phenotype by Rac1-ca.

7\) [Figure 6U](#fig6){ref-type="fig"} and [Figure 7B](#fig7){ref-type="fig"}, are post hoc tests used to confirm where the difference occurs between groups after a statistically significant one-way ANOVA test?

8\) In the Abstract, the authors claim that Crk proteins are recruited to the Frs2/Sjp2/Grb2 signaling complex upon FGF signaling. The author should tone down that assertion because there is no direct evidence that Grb2 is a part of the complex.

9\) In both Introduction and Discussion, many statements referring to published findings lack references. The authors need to revise these sections and add proper citations.

10.7554/eLife.32586.019

Author response

> Essential revisions:
>
> 1\) There were concerns that \"Le-Cre only mice were used as controls.\" It is important to have Le-Cre in the controls, because Le-Cre itself can have an effect on eye development (PLoS One. 2014 Oct 1;9(10):e109193). But it is also important that littermates are used as controls to rule out differences due to genetic background affecting phenotypes (and the Le-Cre alone effect is background dependent!). This is a big problem as the authors would have to repeat a lot of experiments. Short of doing that work, perhaps the authors can argue that there was little or no variation in phenotypes? Thus the authors should mention how many samples were examined (hopefully at least three) and mention somewhere what variation was observed. It might also help to include a table listing all the genetic crosses, with parental genotypes and the important experimental progeny.

We are aware that Le-Cre mice appear normal in the original FVB/N background but present ocular abnormalities in the CBA/Ca background as shown in the citation above, thus we always use Le-Cre mice as controls instead of wild type (+/+) animals. As described in the revised Materials and methods section, we believe such controls are justified because we did not observe any phenotypic differences between Le-Cre and Le-Cre;Crkflox/+;CrkLflox/+ mice in our mixed genetic background. Moreover, lens development was consistent and reproducible among these controls as shown by the modest variations in our quantifications (see [Figure 2E](#fig2){ref-type="fig"} and [4B](#fig4){ref-type="fig"}, for example). The revised Materials and methods section now includes a table of all the genetic crosses and confirms that at least three animals are examined for each genotype.

> 2\) Some other histological phenotypes in the Crk/L-cKO mutants are not adequately described. For example, the lens epithelial layer appears missing ([Figure 2H, J, L, N, P](#fig2){ref-type="fig"}). Also, there is an abnormal optic cub protrusion posterior to the lens vesicle in Crk/L-cKO mutants. The authors need to describe these phenotypes in more detail, and explain how these phenotypes are affected in other mutant backgrounds. If the lens epithelium is indeed disrupted, could this phenotype affect the maintenance of the polarity of primary fibers and the generation of secondary lens fibers? Also, given the lens-specific deletion of Crk/L, why does the mutation cause the abnormality in the optic cup?

We highlight [Figure 2](#fig2){ref-type="fig"} to show that the lens epithelial layer is diminished but not missing in Crk/L-cKO mutants ([Figure 2A and B](#fig2){ref-type="fig"}, arrowheads). Using apical marker Zo-1 and basal marker β1 integrin, we now show that the polarity of the lens fiber cells is also maintained ([Figure 2C](#fig2){ref-type="fig"}). We also cited earlier work that show the disruption of lens development can lead to disorganization of the retina, which we believe explains the protrusion/abnormality of the optic cup in Crk/L-cKO mutants.

> 3\) The authors emphasize the co-expression of the pCrk/L and pERK in the transitional zone, where proliferation and differentiation of secondary lens fibers occurs, at E14.5. However, the Crk/L-cKO lens phenotype appears between E10.5 and E12.5. The authors should compare the pCrk/L and pER expression at these earlier stages to strengthen their argument.

The pCrk/L and pERK expressions at E12.5 are now added to [Figure 1B](#fig1){ref-type="fig"} and [Figure 3D](#fig3){ref-type="fig"}, respectively.

> 4). In [Figure 3C](#fig3){ref-type="fig"}, it appears that the loss of Crk/L mainly affects the substantiation of pERK after FGF2 treatment. Quantification of the western blotting should be very informative here. It would be interesting that Crk/L modify the quantity of FGF-ERK signaling by prolonging ERK activation.

Good advice. We have quantified the western blots in [Figure 3C](#fig3){ref-type="fig"}, which indeed showed that depletion of Crk/L reduced both the intensity and duration of FGF-ERK signaling. This interesting observation is now described in the text.

> 5\) \"Despite the severe morphological defects, Prox1, Pax6 and multiple forms of crystallin (α,β,γ) were expressed without delay ([Figure 2A-N](#fig2){ref-type="fig"}).\" The provided data do not demonstrate the normal onset of Pax6. The authors need to modify the statement or provide additional data to support the statement. Also, authors should indicate that the Pax6+ lens epithelium is greatly reduced and shifted to the ventral position in the mutant.

We agree. This sentence is revised to only state that these lens markers are still expressed in the Crk/L-cKO mutant lens and it is noted that the lens epithelium is diminished and rotated ventrally.

> 6\) [Figure 6H](#fig6){ref-type="fig"}, the authors should provide quantitative data to demonstrate the partial rescue of the Crk/L-cKO phenotype by Rac1-ca.

The quantification is presented in [Figure 6U](#fig6){ref-type="fig"} (the last two columns).

> 7\) [Figure 6U](#fig6){ref-type="fig"} and [Figure 7B](#fig7){ref-type="fig"}, are post hoc tests used to confirm where the difference occurs between groups after a statistically significant one-way ANOVA test?

As now described in the figure legends, Tukey\'s multiple comparisons test was used after one-way ANOVA test.

> 8\) In the Abstract, the authors claim that Crk proteins are recruited to the Frs2/Sjp2/Grb2 signaling complex upon FGF signaling. The author should tone down that assertion because there is no direct evidence that Grb2 is a part of the complex.

Agree. The modified sentence now only note that Crk proteins interact with Grb2 upon FGF signaling.

> 9\) In both Introduction and Discussion, many statements referring to published findings lack references. The authors need to revise these sections and add proper citations.

We apologize for the oversight and added additional references as we have originally intended to.
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